266 related articles for article (PubMed ID: 19285098)
1. Transcriptomic configuration of mouse brain induced by adolescent exposure to 3,4-methylenedioxymethamphetamine.
Eun JW; Kwack SJ; Noh JH; Jung KH; Kim JK; Bae HJ; Xie H; Ryu JC; Ahn YM; Min JH; Park WS; Lee JY; Rhee GS; Nam SW
Toxicol Appl Pharmacol; 2009 May; 237(1):91-101. PubMed ID: 19285098
[TBL] [Abstract][Full Text] [Related]
2. Identification of post-generation effect of 3,4-methylenedioxymethamphetamine on the mouse brain by large-scale gene expression analysis.
Eun JW; Kwack SJ; Noh JH; Jung KH; Kim JK; Bae HJ; Xie H; Ryu JC; Ahn YM; Park WS; Lee JY; Rhee GS; Nam SW
Toxicol Lett; 2010 May; 195(1):60-7. PubMed ID: 20188158
[TBL] [Abstract][Full Text] [Related]
3. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
4. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
Green AR; Mechan AO; Elliott JM; O'Shea E; Colado MI
Pharmacol Rev; 2003 Sep; 55(3):463-508. PubMed ID: 12869661
[TBL] [Abstract][Full Text] [Related]
5. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
[TBL] [Abstract][Full Text] [Related]
6. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
Clemens KJ; McGregor IS; Hunt GE; Cornish JL
Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831
[TBL] [Abstract][Full Text] [Related]
7. Early loss of dopaminergic terminals in striosomes after MDMA administration to mice.
Granado N; Escobedo I; O'Shea E; Colado I; Moratalla R
Synapse; 2008 Jan; 62(1):80-4. PubMed ID: 17960765
[TBL] [Abstract][Full Text] [Related]
8. Developmental exposure to 3,4-methylenedioxymethamphetamine results in downregulation of neurogenesis in the adult mouse hippocampus.
Cho KO; Rhee GS; Kwack SJ; Chung SY; Kim SY
Neuroscience; 2008 Jun; 154(3):1034-41. PubMed ID: 18511203
[TBL] [Abstract][Full Text] [Related]
9. Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.
Daumann J; Till B; Fischermann T; Rezk M; Gouzoulis-Mayfrank E
J Psychopharmacol; 2006 Mar; 20(2):236-44. PubMed ID: 16510481
[TBL] [Abstract][Full Text] [Related]
10. Loud noise enhances nigrostriatal dopamine toxicity induced by MDMA in mice.
Gesi M; Ferrucci M; Giusiani M; Lenzi P; Lazzeri G; Alessandrì MG; Salvadorini A; Fulceri F; Pellegrini A; Fornai F; Paparelli A
Microsc Res Tech; 2004 Jul; 64(4):297-303. PubMed ID: 15481049
[TBL] [Abstract][Full Text] [Related]
11. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
Gouzoulis-Mayfrank E; Daumann J
J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
[TBL] [Abstract][Full Text] [Related]
12. Neurotoxicity mechanisms of thioether ecstasy metabolites.
Capela JP; Macedo C; Branco PS; Ferreira LM; Lobo AM; Fernandes E; Remião F; Bastos ML; Dirnagl U; Meisel A; Carvalho F
Neuroscience; 2007 Jun; 146(4):1743-57. PubMed ID: 17467183
[TBL] [Abstract][Full Text] [Related]
13. Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain.
Bull EJ; Porkess V; Rigby M; Hutson PH; Fone KC
J Psychopharmacol; 2006 Mar; 20(2):272-80. PubMed ID: 16510485
[TBL] [Abstract][Full Text] [Related]
14. Altered gene expression in frontal cortex and midbrain of 3,4-methylenedioxymethamphetamine (MDMA) treated mice: differential regulation of GABA transporter subtypes.
Peng W; Simantov R
J Neurosci Res; 2003 Apr; 72(2):250-8. PubMed ID: 12672000
[TBL] [Abstract][Full Text] [Related]
15. Active and passive MDMA ('ecstasy') intake induces differential transcriptional changes in the mouse brain.
Fernàndez-Castillo N; Orejarena MJ; Ribasés M; Blanco E; Casas M; Robledo P; Maldonado R; Cormand B
Genes Brain Behav; 2012 Feb; 11(1):38-51. PubMed ID: 21951708
[TBL] [Abstract][Full Text] [Related]
16. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
Gouzoulis-Mayfrank E; Daumann J
Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
[TBL] [Abstract][Full Text] [Related]
17. Neurotoxic effects of MDMA (ecstasy) on the developing rodent brain.
Dzietko M; Sifringer M; Klaus J; Endesfelder S; Brait D; Hansen HH; Bendix I; Felderhoff-Mueser U
Dev Neurosci; 2010 Aug; 32(3):197-207. PubMed ID: 20616555
[TBL] [Abstract][Full Text] [Related]
18. Ecstasy: are animal data consistent between species and can they translate to humans?
Easton N; Marsden CA
J Psychopharmacol; 2006 Mar; 20(2):194-210. PubMed ID: 16510478
[TBL] [Abstract][Full Text] [Related]
19. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.
Reneman L; de Win MM; van den Brink W; Booij J; den Heeten GJ
J Psychopharmacol; 2006 Mar; 20(2):164-75. PubMed ID: 16510475
[TBL] [Abstract][Full Text] [Related]
20. Dissociation between serotonin neurotoxicity and brain-derived neurotrophic factor induction following neonatal MDMA exposure in rats.
Piper BJ; Farelli JD; Meyer JS
Dev Neurosci; 2009; 31(1-2):90-4. PubMed ID: 19372690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
